
Health care special purpose acquisition companies in 2020-2021 represented a temporary market inefficiency that enabled weaker companies to bypass traditional due diligence and ultimately led to failures.
Supplements and Featured Publications
This article provides a comprehensive summary of the latest evidence on continuous glucose monitoring (CGM) and its evolving impact on diabetes care. Read here to learn why increased implementation and expanded use of CGM’s should improve clinical outcomes and reduce diabetes-related health care costs.






